Rex Healthcare Selects Global Med's SafeTrace(R) Application to Manage its Blood Services Program
December 17 2003 - 10:00AM
PR Newswire (US)
Rex Healthcare Selects Global Med's SafeTrace(R) Application to
Manage its Blood Services Program DENVER, Dec. 17
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of
Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global
Med" or the "Company"), announced the signing of an agreement for
its SafeTrace(R) donor management system with Rex Healthcare
located in Raleigh, North Carolina. Terms of the agreement were not
disclosed. "We chose SafeTrace because of its built-in safety
features, which will help us provide high quality services to our
donors, which in turn enhances the quality of blood products for
our patients," said Dr. Timothy Carter, Laboratory Director at Rex
Healthcare. Dr. Carter added, "Additionally, SafeTrace provides
donor recruitment tools that we plan to use for expansion of our
donor base and improved donor retention." Thomas F. Marcinek,
President and COO of Global Med Technologies, Inc., said, "We are
very pleased that Rex Healthcare selected SafeTrace to manage its
blood services program." Mr. Marcinek added, "Rex Healthcare joins
our growing list of prestigious clients using our products to help
them provide the highest standard of care and services to blood
donors and patients." About Rex Healthcare Rex Healthcare is a
private, not-for-profit health care system that has provided
superior care to Wake County and the surrounding area since 1894.
The Rex hospital campus is the heart of the Rex Healthcare network,
including a 394-bed acute care hospital, family birth center,
cancer center, convalescent care center, same day surgery center,
heart & vascular center and wellness center. For more
information about Rex Healthcare, visit its website at
http://www.rexhealth.com/ . About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an e-Health, medical information
technology company, providing information management software
products and services to the healthcare industry. Its Wyndgate
Technologies division is a leading supplier of information
management systems to U.S. blood centers and transfusion services.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Together, SafeTrace Tx(R)* and SafeTrace provide
Vein-to- Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, call 800-WYNDGATE or visit http://www.globalmedtech.com/
, http://www.peoplemed.com/ and http://www.wyndgate.com/ . This
news release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. *Patent Pending
DATASOURCE: Global Med Technologies, Inc. CONTACT: Press Inquiries,
Patti Larson, Senior Director of Marketing Development,
+1-916-404-8492, , or Investor Inquiries, Tom Marcinek, President
and COO, +1-916-404-8413, , both of Wyndgate Technologies, for
Global Med Technologies, Inc. Web site: http://www.peoplemed.com/
Web site: http://www.rexhealth.com/ Web site:
http://www.globalmedtech.com/
Copyright